Braveheart Bio Inc. Company Profile
NASDAQ: BRVEHealth CareBiotechnology: Pharmaceutical PreparationsUSD
At close: Oct 8, 4:00 PM ET · Delayed 15 min
Braveheart Bio at a glance
Braveheart Bio Inc. (NASDAQ: BRVE) is a Biotechnology: Pharmaceutical Preparations company in the Health Care sector headquartered in San Francisco, CA. Braveheart Bio is led by Dr. Travis Murdoch B.S., M.D., M.Sc. and employs about 49 people. The company's shares have traded publicly since 2026.
At a market capitalization of $1.72 billion, it is considered a small-cap company. Its SEC Central Index Key (CIK) is 0002131524, which identifies the company's filings on EDGAR.
Summary generated from market data by MetaCap's automated system. Methodology
What does Braveheart Bio do?
Braveheart Bio, Inc. a clinical-stage biopharmaceutical company focused on developing therapies for patients with hypertrophic cardiomyopathy (HCM) and other serious cardiovascular diseases. It develops and offers BHB-1893 and HRS-1893, an oral small-molecule cardiac myosin inhibitor (CMI) for the treatment of obstructive HCM and non-obstructive HCM. The company was incorporated in 2024 and is headquartered in San Francisco, California.
Business description based on the company's public filings.
Company information
- Legal name
- Braveheart Bio Inc.
- Ticker
- NASDAQ: BRVE
- Sector
- Health Care
- Industry
- Biotechnology: Pharmaceutical Preparations
- CEO
- Dr. Travis Murdoch B.S., M.D., M.Sc.
- Employees
- 49
- Headquarters
- One Letterman Drive, San Francisco, CA, United States
- Phone
- 415 707 6312
- Website
- braveheart.bio
- IPO year
- 2026
- Market cap
- $1.72B
- SEC CIK
- 0002131524
Companies similar to Braveheart Bio
| Company | Price | % Chg | Market cap | Compare |
|---|---|---|---|---|
| SEPNSepterna Inc. | 36.90 | +2.50% | $1.72B | vs BRVE |
| ZBIOZenas BioPharma Inc. | 26.24 | -6.88% | $1.71B | vs BRVE |
| NUVBNuvation Bio Inc. Class A | 4.95 | +1.85% | $1.74B | vs BRVE |
| ANIPANI Pharmaceuticals Inc. | 71.98 | +0.07% | $1.65B | vs BRVE |
| OCULOcular Therapeutix Inc. | 7.51 | +3.87% | $1.65B | vs BRVE |
| GENBGenerate Biomedicines Inc. | 13.99 | +3.10% | $1.80B | vs BRVE |
| BHVNBiohaven Ltd. | 11.93 | +0.42% | $1.80B | vs BRVE |
| URGNUroGen Pharma Ltd. | 36.98 | -9.14% | $1.81B | vs BRVE |